Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Wolpin, Brian Matthew

Dana-Farber Cancer Inst
United States

 Altered metabolism and machine learning for pancreatic cancer early detection 2U01CA210171-06 PAR-21-334 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Pitteri, Sharon

Stanford University
United States

 Glycosylation and Immune Evasion in Urologic Tumors 5U01CA226051-04 PAR-17-206 (U01) Richard Mazurchuk, Ph.D.
Schloss, Patrick David

University Of Michigan At Ann Arbor
United States

 muMS2: an open source R package for analyzing and integrating multi-omics datasets to improve early detection and understanding of colorectal cancer 1U01CA264071-01A1 RFA-CA-21-014 (U01 Clinical Trial Optional) Christos Patriotis, Ph.D., M.Sc.
Lin, Jia-Ren

Harvard Medical School
United States

 Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images 1R50CA274277-01 Richard Mazurchuk, Ph.D.
Carter, Bob S

Massachusetts General Hospital
United States

 Standardized Molecular Analyses of Glioma EVs 5R01CA237500-03 PAR-16-276 (R01) Matthew Young, Ph.D.
Zarrinpar, Amir

University Of California, San Diego
United States

 Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-02 Sharmistha Ghosh-Janjigian, Ph.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

 The microbiome ecosystem of Barrett's esophagus and progression to cancer 1R21CA259687-01A1 PAR-20-292 (R21 Clinical Trial Optional) Matthew Young, Ph.D.
Mckeon, Frank D.

University Of Houston
United States

 Clonal Reconstruction and Targeting of the Correa Sequence 5R01CA241600-04 Matthew Young, Ph.D.
Zhou, Xianghong Jasmine

University Of California Los Angeles
United States

 The UCLA Center in Early Detection of Liver Cancer 5U01CA230705-05 Jo Ann Rinaudo, Ph.D.
Sidransky, David

Johns Hopkins University
United States

 Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma 1R01CA265975-01A1 PAR-21-322 (R01 Clinical Trial Not Allowed) Wendy Wang, Ph.D., M.Sc.